wire - news in brief

A clinical trial under MHH leadership is testing a new therapy with immune cells against the JC virus.

The world is changing quickly and we need to keep learning in order to adapt to new conditions. A new research group headed by Tania Lincoln is looking at how these learning processes can fail and what the consequences are for our psychological health.

International Clinical Trial Shows Alternative to Standard Treatment of Myelodysplastic Neoplasms In people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukaemia, the body produces too few functional blood cells.

In patients suffering from myelodysplastic neoplasms (MDS), a group of often mildly progressing bone marrow disorders, the body does not produce enough functional blood cells.

What framework conditions do children and young people need for good psychosocial development? This is what the MHH and the University of Hildesheim want to find out in a study.

Professor Jürgen Groll has raised around 880,000 euros for a new project. His team wants to use it to lay the foundation for improved multifunctional medical implants and materials .

University of Bonn appoints two new Argelander Professors specializing in organoid biology Two new assistant professors at the University of Bonn are setting out to develop "mini-organs" in order to study metabolic and disease mechanisms. Elena Reckzeh is using these so-called organoids to identify new drug candidates, while Ana Ivonne Vazquez-Armendariz hopes that they can give her a better understanding of lung disease.

In patients affected by myelodysplastic neoplasms (MDS), the body does not produce enough functional blood cells.

Work Hauptgebäude Chemie 04103 Leipzig Phone: work +49 341 97-36000 341 97-36094 Dean Christoph Schneider Vice-Dean Holger Kohlmann Dean of Studies Reinhard Denecke Deanery Marco Weiß Work Institutsg

MHH Cardiology participates in a nationwide project to improve risk assessment thanks to structured and standardized data.

Prototyping grants #2: Healthy sugar, digital health solutions, and improved cancer screening Is there a healthy alternative to sugar?

News from To strengthen its cutting-edge research, Leipzig University submitted three draft proposals yesterday (Wednesday, 31 May 2023) in the Clusters of Excellence funding line in the second competition phase of the Excellence Strategy of the German federal and state governments.

NewIn: Matthias Hebrok In this issue of "NewIn," we introduce Matthias Hebrok. The professor of Applied Stem Cell and Organoid Systems and director of the new TUM Center for Organoid Systems (COS) creates organ-like structures from stem cells.

The project combines computer science, mathematics, statistics, medicine, and systems modelling The use of artificial intelligence even with relatively small biomedical data sets is being strengthene

Reading time 2 min. Government funding for RNA research extended The German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) has extended funding for the "Transregio" Collaborative Research Center "Non-coding RNA in the cardiovascular system" (TRR 267).

The four research consortia in medicine receive finance amounting to approximately 63 million euros In the current approval round of the German Research Foundation (DFG), Heidelberg University has be

For research on improving the quality of health care, the Hamburg Center for Health Economics at Universität Hamburg has created a comprehensive doctoral program.

European Research Council is supporting the journey from basic research to application Two researchers from the University of Bonn have been awarded a Proof of Concept Grant by the European Research

People born deaf use parts of the auditory brain area for vision. However, this does not hinder the recovery of the sense of hearing, MHH researchers found. Humans have five senses to perceive their environment: Sight, hearing, touch, smell and taste. If a person loses one of these, the remaining senses partially compensate for the loss.

The MHH is looking for subjects with an IDH1 gene mutation for a multicenter study on the combination therapy of two drugs previously used individually against acute myeloid leukemia (AML) 28.

Interdisciplinary research project rediscovers lesbian life worlds in the period from 1945 to the 1980s What aftereffects did National Socialism have on women attracted to women after 1945?

University of Bonn's ImmunoSensation2 Cluster of Excellence invites you to join it in the city center on April 29 What possibilities does mRNA technology offer?

Reading time 9 min. Research at the new Center for Multiple Sclerosis and Neurosciences The TUM scientists and physicians and the patients at the Center for Multiple Sclerosis and Neurosciences, to open in 2025, will share a common objective: Making life with multiple sclerosis better. Many open questions will be answered - for example why the illness has such a variety of forms, particularly in its initial stages, and how to stop nerve cell death in the later stages.

German Science and Humanities Council recommends joint research building for Charité and Freie Universität Berlin Anticipate diseases.

The multicentre ChangePDD project compares the effectiveness of two different therapies. MHH Psychiatry is involved and offers places for study participants.